Acad Radiol. 2002 Aug;9 Suppl 2:S304-6

Crosslinked iron oxides (CLIO): a new platform for the development of targeted MR contrast agents

Wunderbaldinger P, Josephson L, Weissleder R.

PMID: 12188255
PubMed Entry